231 related articles for article (PubMed ID: 33565509)
1. Multiparametric magnetic resonance-guided and monitored microwave ablation in liver cancer.
Zhang K; Liu M; Xu Y; He X; Sequeiros RB; Li C
J Cancer Res Ther; 2020; 16(7):1625-1633. PubMed ID: 33565509
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma originating in the caudate lobe: A pilot clinical study.
Peng Y; Cui D; Li W; Ding M; Shi Y; Wang T; Shi D; Chi J; Li P; Zhai B
J Cancer Res Ther; 2021 Jul; 17(3):764-770. PubMed ID: 34269311
[TBL] [Abstract][Full Text] [Related]
3. MR-guided microwave ablation of hepatocellular carcinoma (HCC): is general anesthesia more effective than local anesthesia?
Li Z; Wang C; Li J; Liu Z; Jiao D; Han X
BMC Cancer; 2021 May; 21(1):562. PubMed ID: 34001036
[TBL] [Abstract][Full Text] [Related]
4. Image-guided microwave ablation of hepatocellular carcinoma (≤5.0 cm): is MR guidance more effective than CT guidance?
Li Z; Wang C; Si G; Zhou X; Li Y; Li J; Jiao D; Han X
BMC Cancer; 2021 Apr; 21(1):366. PubMed ID: 33827464
[TBL] [Abstract][Full Text] [Related]
5. MR-guided microwave ablation in hepatic tumours: initial results in clinical routine.
Hoffmann R; Rempp H; Keßler DE; Weiß J; Pereira PL; Nikolaou K; Clasen S
Eur Radiol; 2017 Apr; 27(4):1467-1476. PubMed ID: 27553935
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Microwave and Radiofrequency Ablation for the Treatment of Small- and Medium-Sized Hepatocellular Carcinomas in a Prospective Randomized Trial.
Vogl TJ; Martin SS; Gruber-Rouh T; Booz C; Koch V; Nour-Eldin NA; Hussainy Said MN
Rofo; 2024 May; 196(5):482-490. PubMed ID: 38065541
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter arterial chemoembolization combined with simultaneous DynaCT-guided microwave ablation in the treatment of small hepatocellular carcinoma.
Li Z; Jiao D; Han X; Si G; Li Y; Liu J; Xu Y; Zheng B; Zhang X
Cancer Imaging; 2020 Jan; 20(1):13. PubMed ID: 32000862
[TBL] [Abstract][Full Text] [Related]
8. MR-Guided High-Power Microwave Ablation in Hepatic Malignancies: Initial Results in Clinical Routine.
Winkelmann MT; Gohla G; Kübler J; Weiß J; Clasen S; Nikolaou K; Hoffmann R
Cardiovasc Intervent Radiol; 2020 Nov; 43(11):1631-1638. PubMed ID: 32699978
[TBL] [Abstract][Full Text] [Related]
9. Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study.
Li X; Chen B; An C; Cheng Z; Han Z; Liu F; Yu J; Liang P
J Cancer Res Ther; 2020 Sep; 16(5):1027-1037. PubMed ID: 33004744
[TBL] [Abstract][Full Text] [Related]
10. The pilot experience upon surgical ablation of large liver tumor by microwave system with tissue permittivity feedback control mechanism.
Liang PC; Lai HS; Shih TT; Wu CH; Huang KW
BMC Surg; 2014 Oct; 14():82. PubMed ID: 25336074
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant cytokine-induced killer cells with minimally invasive therapies augmented therapeutic efficacy of unresectable hepatocellular carcinoma.
Huang ZM; Lai CX; Zuo MX; An C; Wang XC; Huang JH; Ning E
J Cancer Res Ther; 2020; 16(7):1603-1610. PubMed ID: 33565506
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging-guided microwave ablation of hepatic malignancies: Feasibility, efficacy, safety, and follow-up.
Yang N; Gong J; Yao L; Wang C; Chen J; Liu J; Wang Z; Lu J
J Cancer Res Ther; 2020 Sep; 16(5):1151-1156. PubMed ID: 33004763
[TBL] [Abstract][Full Text] [Related]
13. Current use of percutaneous image-guided tumor ablation for the therapy of liver tumors: lessons learned from the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR) 2018-2022.
Zensen S; Bücker A; Meetschen M; Haubold J; Opitz M; Theysohn JM; Schramm S; Jochheim L; Kasper S; Forsting M; Schaarschmidt BM
Eur Radiol; 2024 May; 34(5):3322-3330. PubMed ID: 37935847
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy by transarterial injection of miriplatin-iodized oil suspension with radiofrequency ablation (RFA) versus microwave ablation (MWA) for small hepatocellular carcinoma: a comparison of therapeutic efficacy.
Miyamoto N; Kanaya M; Fujii T; Kato H; Kudo K; Kinota N
Jpn J Radiol; 2021 Apr; 39(4):376-386. PubMed ID: 33150469
[TBL] [Abstract][Full Text] [Related]
15. Balloon-Occluded MWA (b-MWA) Followed by Balloon-Occluded TACE (b-TACE): Technical Note on a New Combined Single-Step Therapy for Single Large HCC.
Iezzi R; Posa A; Tanzilli A; Carchesio F; Pompili M; Manfredi R
Cardiovasc Intervent Radiol; 2020 Nov; 43(11):1702-1707. PubMed ID: 32676963
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update.
Izzo F; Granata V; Grassi R; Fusco R; Palaia R; Delrio P; Carrafiello G; Azoulay D; Petrillo A; Curley SA
Oncologist; 2019 Oct; 24(10):e990-e1005. PubMed ID: 31217342
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial.
Vietti Violi N; Duran R; Guiu B; Cercueil JP; Aubé C; Digklia A; Pache I; Deltenre P; Knebel JF; Denys A
Lancet Gastroenterol Hepatol; 2018 May; 3(5):317-325. PubMed ID: 29503247
[TBL] [Abstract][Full Text] [Related]
18. 3D visualization ablation planning system assisted microwave ablation for hepatocellular carcinoma (Diameter >3): a precise clinical application.
An C; Li X; Zhang M; Yang J; Cheng Z; Yu X; Han Z; Liu F; Dong L; Yu J; Liang P
BMC Cancer; 2020 Jan; 20(1):44. PubMed ID: 31959147
[TBL] [Abstract][Full Text] [Related]
19. Feasibility and efficacy of superconducting open-configuration magnetic resonance-guided microwave ablation of malignant liver tumors with real-time imaging sequences.
Yuan H; Shen L; Qi H; Wang X; Tan H; Cao F; Huang T; Li D; Zhang Y; Wang T; Wu Y; Fan W
J Cancer Res Ther; 2022 Apr; 18(2):384-390. PubMed ID: 35645104
[TBL] [Abstract][Full Text] [Related]
20. Analysis on efficacy and safety of TACE in combination with RFA and MWA in the treatment of middle and large primary hepatic carcinoma.
Yuan P; Zhang Z; Kuai J
J BUON; 2019; 24(1):163-170. PubMed ID: 30941966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
